POLYDEX PHARMACEUTICALS LTD/BAHAMAS
10-Q, EX-27, 2000-09-13
PHARMACEUTICAL PREPARATIONS
Previous: POLYDEX PHARMACEUTICALS LTD/BAHAMAS, 10-Q, 2000-09-13
Next: PEOPLES BANCORP INC, 3, 2000-09-13



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          JAN-31-2001
<PERIOD-START>                             FEB-01-2000
<PERIOD-END>                               JUL-31-2000
<CASH>                                         659,300
<SECURITIES>                                         0
<RECEIVABLES>                                  897,918
<ALLOWANCES>                                    16,969
<INVENTORY>                                  2,163,716
<CURRENT-ASSETS>                             3,750,712
<PP&E>                                      10,170,981
<DEPRECIATION>                               4,987,938
<TOTAL-ASSETS>                              11,234,669
<CURRENT-LIABILITIES>                        2,161,590
<BONDS>                                      1,001,175
                                0
                                     15,010
<COMMON>                                        50,350
<OTHER-SE>                                  23,151,085
<TOTAL-LIABILITY-AND-EQUITY>                11,234,669
<SALES>                                      6,498,727
<TOTAL-REVENUES>                             6,498,727
<CGS>                                        4,718,640
<TOTAL-COSTS>                                4,718,640
<OTHER-EXPENSES>                             1,557,497
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             150,788
<INCOME-PRETAX>                                 92,332
<INCOME-TAX>                                   167,012
<INCOME-CONTINUING>                           (74,680)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (74,680)
<EPS-BASIC>                                     (0.02)
<EPS-DILUTED>                                   (0.02)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission